GOLD2023EN
GOLD 2023 Report: Global Strategy for Prevention, Diagnosis and Management of COPD
Zusammenfassung
Page 1 of 16
GOLD 2023 KEY CHANGES SUMMARY
References, Tables & Figures
In total 387 new references have been added to the GOLD 2023 report as listed alphabetically at the end of this
document.
Tables and Figures have been redesigned and minor amendments and corrections have been made to many. In
addition, the following new Tables and Figures have been added to the GOLD 2023 report:
Table 1.1 Proposed Taxonomy (Etiotypes) for COPD
Table 2.8 Use of
Kerninformationen
able has been added with information on the Evidence Supporting a Reduction in Mortality with
Pharmacotherapy and Non-pharmacotherapy in COPD Patients (Table 3.6)
► Issues Related to Inhaled Delivery have been addressed (Page 69)
► Information on the topic of Adherence to Inhaled COP...
and Comorbidities has been updated with the latest evidence.
Chapter 7
► The chapter on COVID-19 and COPD has been updated with new references and the latest evidence.
NEW REFERENCES ADDED
References added to Chapters 1-7 (listed alphabetically)
1. Abdelsattar ZM, Allen M, Blackmon S, et al. ...
ology 2022; 27(11): 929-40.
10. Allinson JP, Afzal S, Colak Y, et al. Changes in lung function in European adults born between 1884 and 1996 and
implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies. Lancet Respir
Med 2022; 10(1): 83-94.
11. A...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
GOLD2024
GOLD 2024 Report: Global Strategy for Prevention, Diagnosis and Management of COPD
GOLD2024
GOLD 2024 Report: Global Strategy for the Diagnosis, Management, and Prevention of COPD
GOLD2024
GOLD 2024: Global Strategy for the Diagnosis, Management, and Prevention of COPD
GOLD2025
GOLD 2025 Report: Global Strategy for Prevention, Diagnosis and Management of COPD
GOLD2025